CGTX – cognition therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Cognition Therapeutics Targets Faster DLB Psychosis Path as Zervimesine Nears Late-Stage Plans [Yahoo! Finance]
Cognition Therapeutics to Present at Needham Virtual Healthcare Conference
Cognition Therapeutics CEO Issues Letter to Shareholders [Yahoo! Finance]
Cognition Therapeutics CEO Issues Letter to Shareholders
Cognition Therapeutics (CGTX) had its "buy" rating reaffirmed by Chardan Capital. They now have a $4.00 price target on the stock.
Form S-8 COGNITION THERAPEUTICS
Form 10-K COGNITION THERAPEUTICS For: Dec 31
Form 8-K COGNITION THERAPEUTICS For: Mar 26
Form 8-K COGNITION THERAPEUTICS For: Mar 02
Form 4 COGNITION THERAPEUTICS For: Feb 15 Filed by: Ricciardi Lisa
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.